GHRP-6 5mg ×5 + CJC-1295 5mg ×5 (Bundle)
CAS: GHRP-6: 87616-84-0 | CJC-1295 (no DAC): 863288-34-0
The GHRP-6 & CJC-1295 5mg ×5 Bundle by BioPeptides is a high-purity research-grade peptide combination developed for advanced laboratory studies in growth hormone signaling, endocrine pathway analysis, and receptor interaction research. This bundle includes GHRP-6 (CAS 87616-84-0) and CJC-1295 no DAC (CAS 863288-34-0), supplied in multiple 5mg vials for experimental flexibility and reproducibility. Purified to ≥99% HPLC, the peptides provide reliable molecular accuracy for controlled in-vitro and biochemical research. Laboratories across Europe rely on BioPeptides to buy peptides online with confidence through EU-friendly shipping and verified analytical documentation.
$680.00
Research Use Only
GHRP-6 & CJC-1295 Research Overview
The GHRP-6 & CJC-1295 bundle combines two peptides commonly studied for their role in growth hormone signaling and endocrine pathway regulation.
GHRP-6 acts as a growth hormone secretagogue interacting with ghrelin receptors and influencing GH release signaling pathways.
CJC-1295 (no DAC) is a synthetic analog of growth hormone releasing hormone (GHRH) used to stimulate pituitary GH release pathways.
Together, these peptides allow researchers to investigate receptor coordination, signal amplification, endocrine feedback mechanisms, and downstream cellular responses in controlled research environments.
Scientific Background of GHRP-6 & CJC-1295
Growth hormone signaling involves complex endocrine pathways regulated by releasing hormones and secretagogue peptides.
CJC-1295 mimics the biological activity of GHRH, activating pituitary receptors responsible for GH secretion signaling.
GHRP-6 activates the ghrelin receptor pathway, influencing endocrine signaling through a complementary mechanism.
Combining these peptides enables researchers to investigate receptor synergy, endocrine coordination, feedback loops, and signaling efficiency.
Mechanistic Research Perspective
- Ghrelin receptor activation and secretagogue signaling pathway analysis
- GHRH receptor interaction and pituitary pathway investigation
- Dual-pathway endocrine signaling research
- Receptor cross-talk and hormonal feedback loop analysis
- Growth hormone release pathway modeling
Primary Research Applications
Growth Hormone Release Pathway Studies: Researchers use the bundle to analyze GH secretion dynamics, receptor activation timing, and signaling efficiency under controlled laboratory conditions.
Endocrine System Modeling: The peptide combination allows scientists to examine hormonal regulation systems and pituitary pathway coordination.
Receptor Interaction Studies: The bundle supports investigation of ghrelin receptor and GHRH receptor cross-talk and ligand-receptor interaction dynamics.
Cellular Signaling Research: Laboratories apply the peptides in cell-based assays analyzing intracellular signaling cascades and gene expression responses.
In-Vitro & Preclinical Research Models: The bundle is widely used in controlled in-vitro models investigating endocrine signaling without therapeutic intent.
Molecular Characteristics
- Peptide Type: Growth hormone secretagogue and GHRH analog
- GHRP-6 CAS Identifier: 87616-84-0
- CJC-1295 (no DAC) CAS Identifier: 863288-34-0
- GHRP-6 Molecular Weight: ~873.0 g/mol
- CJC-1295 Molecular Weight: ~3367.95 g/mol
- Form: Lyophilized peptide powders supplied in separate vials
Stability Profile and Storage Recommendations
- Store lyophilized peptides at −20°C for long-term stability
- Protect vials from moisture and direct light exposure
- Avoid repeated freeze–thaw cycles after reconstitution
- Reconstitute using sterile laboratory-grade solvent
- Handle peptides using aseptic laboratory techniques
Solubility and Reconstitution Options
- Sterile bacteriostatic water
- Sterile saline solutions
- Buffered aqueous laboratory solutions
- Standard biochemical assay buffers
- Laboratory-grade solvent systems
Technical Specifications
product Name
GHRP-6 5mg ×5 + CJC-1295 5mg ×5 Bundle
brand
BioPeptides
cas
87616-84-0 | 863288-34-0
purity
≥99% (HPLC verified)
unit Size
5mg ×5 vials each peptide
form
Lyophilized powder (separate vials)
synthesis
Solid-Phase Peptide Synthesis (SPPS)
analytical
HPLC, Mass Spectrometry
molecular Structure
Synthetic peptide hormones
stability
High when stored appropriately
Analytical Validation and Quality Assurance
- High-performance liquid chromatography (HPLC) purity verification
- Mass spectrometry molecular weight confirmation
- Structural integrity and peptide sequence validation
- Batch-to-batch consistency testing
- Peptide stability and analytical verification
Frequently Asked Questions
This bundle is used in laboratory research to study growth hormone release mechanisms, endocrine signaling coordination, receptor interaction, and pathway amplification in controlled, non-clinical research environments.
GHRP-6 is studied for its strong ghrelin receptor activation and distinct signaling behavior, making it useful for comparative studies against other GH secretagogues such as GHRP-2 or Ipamorelin.
Researchers combine CJC-1295 and GHRP-6 to investigate dual-pathway GH signaling, allowing analysis of receptor synergy, signal timing, and endocrine feedback regulation.
Yes. Each peptide is supplied in individual 5mg vials, which improves stability, supports flexible experimental design, and reduces degradation during long-term research.
Yes. The bundle is widely used in controlled in-vitro and preclinical research models focused on receptor binding, intracellular signaling, and endocrine pathway analysis.
Store lyophilized vials at -20°C, reconstitute only with sterile laboratory solvent, and avoid repeated freeze-thaw cycles to maintain molecular stability.
Yes. BioPeptides ships this research bundle across Europe using secure, EU-compliant logistics and professional research packaging.
BioPeptides is trusted for high-purity synthesis, verified CAS documentation, consistent batch quality, and strict adherence to European research standards.